Correspondence 0001493152-22-033951 from ONCOSEC MEDICAL Inc (ONCSQ) (CIK 0001444307)
ONCOSEC MEDICAL Inc (ONCSQ) (CIK 0001444307)
Date: Nov. 29, 2022 · CIK: 0001444307 · Accession: 0001493152-22-033951
AI Filing Summary & Sentiment
File numbers found in text: 333-268081
Letter
OncoSec Medical Incorporated
24 North Main Street
Pennington, NJ 08534
(855) 622-6732
November 29, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
F Street N.E.
Washington, D.C. 20549
Re: OncoSec Medical Incorporated
Registration Statement on Form S-1/A
Filed November 29, 2022
File No. 333-268081
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentleman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), OncoSec Medical Incorporated, a Nevada corporation (the “Company”), respectfully requests that the effective date of the above-referenced Amendment No. 4 to the Registration Statement on Form S-1 (File No. 333-268081) be accelerated by the Securities and Exchange Commission (the “Commission”) so that it will be declared effective at 9:00 am., Eastern Time, on Wednesday, November 30, 2022, or as soon thereafter as is practicable.
The Registrant understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed public offering of the securities specified in the Registration Statement.
Please call Christopher L. Tinen, Esq. of Procopio, Cory, Hargreaves & Savitch LLP at (858) 720-6320 as soon as the Registration Statement has been declared effective.
Very Truly Yours,
OncoSec Medical Incorporated
Show Raw Text
CORRESP
1
filename1.htm
OncoSec
Medical Incorporated
24 North Main Street
Pennington, NJ 08534
(855) 622-6732
November
29, 2022
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street N.E.
Washington,
D.C. 20549
Re:
OncoSec
Medical Incorporated
Registration
Statement on Form S-1/A
Filed
November 29, 2022
File
No. 333-268081
REQUEST
FOR ACCELERATION OF EFFECTIVENESS
Ladies
and Gentleman:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), OncoSec Medical Incorporated, a Nevada corporation
(the “Company”), respectfully requests that the effective date of the above-referenced Amendment No. 4 to the Registration
Statement on Form S-1 (File No. 333-268081) be accelerated by the Securities and Exchange Commission (the “Commission”) so
that it will be declared effective at 9:00 am., Eastern Time, on Wednesday, November 30, 2022, or as soon thereafter as is practicable.
The
Registrant understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement
as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed
public offering of the securities specified in the Registration Statement.
Please
call Christopher L. Tinen, Esq. of Procopio, Cory, Hargreaves & Savitch LLP at (858) 720-6320 as soon as the Registration Statement
has been declared effective.
Very Truly Yours,
OncoSec Medical Incorporated
By:
/s/
Robert H. Arch
Name:
Robert
H. Arch
Title:
President
and Chief Executive Officer